Synonyms:
Status: Phase 3
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: Q16CT95N25

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Phosphatidylserine inhibitor PubMed PubMed Other

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Carcinoma, Non-Small-Cell Lung 3 D002289 ClinicalTrials
Pancreatic Neoplasms 2 D010190 ClinicalTrials
Carcinoma, Hepatocellular 2 D006528 ClinicalTrials
Carcinoma 2 D002277 ClinicalTrials
Glioblastoma 2 D005909 ClinicalTrials
Triple Negative Breast Neoplasms 2 D064726 ClinicalTrials
Carcinoma, Squamous Cell 2 D002294 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials
Hepatitis C 1 D006526 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Melanoma 1 D008545 ClinicalTrials
Breast Neoplasms, Male 1 D018567 ClinicalTrials
Rectal Neoplasms 1 D012004 ClinicalTrials
Prostatic Neoplasms 1 D011471 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 648904-28-3
ChEMBL CHEMBL1742989
FDA SRS Q16CT95N25
Guide to Pharmacology 8002